Yes and more specifically, in Western Australia. I have friends that have been directly involved in attempting to gain approvals for exploration companies looking to take the next step, in areas outside of WA and have also owned shares in a few myself. None of us can't tell you how guttered one feels watching millions of dollars and years of work go down the drain when submissions are rejected. This one will get up.
I also can't explain the loss I feel, watching LYC rocket ahead, after selling out some time ago under 50c. This one won't get away from me.
A few good, long awaited announcements and we should see a significant up-tick. It's just a waiting game now lads and ladies.
- Forums
- ASX - By Stock
- HAS
- How does HAS differentiate against other RE players
How does HAS differentiate against other RE players, page-99
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
Add HAS (ASX) to my watchlist
|
|||||
Last
41.5¢ |
Change
-0.010(2.35%) |
Mkt cap ! $75.04M |
Open | High | Low | Value | Volume |
42.0¢ | 42.5¢ | 40.0¢ | $426.5K | 1.020M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 48838 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 10164 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 48838 | 0.415 |
4 | 22317 | 0.410 |
3 | 19993 | 0.405 |
6 | 48499 | 0.400 |
2 | 26507 | 0.395 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 10164 | 1 |
0.430 | 46904 | 1 |
0.435 | 6896 | 1 |
0.440 | 36712 | 3 |
0.445 | 66120 | 4 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
HAS (ASX) Chart |